NHBE cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PITX3 | hg19_v2_chr10_-_104001231_104001274 | 0.21 | 7.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153013588 Show fit | 2.14 |
ENST00000360379.3
|
small proline-rich protein 2D |
|
chr15_-_80263506 Show fit | 1.13 |
ENST00000335661.6
|
BCL2-related protein A1 |
|
chr12_+_22852791 Show fit | 0.99 |
ENST00000413794.2
|
RP11-114G22.1 |
|
chr17_-_38859996 Show fit | 0.88 |
ENST00000264651.2
|
keratin 24 |
|
chr6_-_10694766 Show fit | 0.84 |
ENST00000460742.2
ENST00000259983.3 ENST00000379586.1 |
chromosome 6 open reading frame 52 |
|
chr1_-_153363452 Show fit | 0.83 |
ENST00000368732.1
ENST00000368733.3 |
S100 calcium binding protein A8 |
|
chr1_-_153113927 Show fit | 0.79 |
ENST00000368752.4
|
small proline-rich protein 2B |
|
chr19_-_6690723 Show fit | 0.79 |
ENST00000601008.1
|
complement component 3 |
|
chr8_-_25281747 Show fit | 0.77 |
ENST00000421054.2
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
chr8_-_150563 Show fit | 0.72 |
ENST00000523795.2
|
Protein LOC100286914 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 1.3 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 1.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.9 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.8 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.8 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.7 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 1.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 1.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.8 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.5 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.0 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 0.6 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.9 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |